Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LEIF BERTELSEN DENTAL LABORATORIUM ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   2.5% 2.7% 2.8% 3.1% 4.9% 4.0% 11.6% 11.3%   Credit score (0-100)   64 60 57 56 43 50 21 21   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,450 1,502 1,440 1,463 1,060 839 0.0 0.0   EBITDA   371 313 285 267 -140 -15.5 0.0 0.0   EBIT   315 236 216 200 -207 -68.1 0.0 0.0   Pre-tax profit (PTP)   311.5 230.4 209.1 194.1 -206.8 -72.7 0.0 0.0   Net earnings   256.0 176.6 163.1 147.6 -200.0 -71.9 0.0 0.0   Pre-tax profit without non-rec. items   311 230 209 194 -207 -72.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   417 340 270 204 137 84.0 0.0 0.0   Shareholders equity total   1,072 1,148 1,211 1,245 927 733 533 533   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,372 1,507 1,480 1,467 1,163 957 533 533   Net Debt   -492 -710 -742 -639 -582 -451 -533 -533     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,450 1,502 1,440 1,463 1,060 839 0.0 0.0   Gross profit growth   16.6% 3.6% -4.2% 1.7% -27.5% -20.9% -100.0% 0.0%   Employees   0 0 0 0 0 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,372 1,507 1,480 1,467 1,163 957 533 533   Balance sheet change%   19.1% 9.8% -1.8% -0.9% -20.7% -17.8% -44.3% 0.0%   Added value   370.5 313.5 285.2 267.2 -140.4 -15.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   262 -155 -139 -134 -134 -105 -84 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.7% 15.7% 15.0% 13.7% -19.6% -8.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.0% 16.4% 14.4% 13.6% -15.4% -6.0% 0.0% 0.0%   ROI %   31.7% 21.2% 18.1% 16.2% -18.5% -7.6% 0.0% 0.0%   ROE %   25.8% 15.9% 13.8% 12.0% -18.4% -8.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   78.1% 76.2% 81.9% 84.8% 79.7% 76.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -132.8% -226.5% -260.3% -239.0% 414.2% 2,905.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   2.8 3.0 4.2 5.4 3.7 3.3 0.0 0.0   Current Ratio   3.1 3.3 4.6 5.8 4.1 3.6 0.0 0.0   Cash and cash equivalent   492.2 710.0 742.3 638.6 581.6 451.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   635.7 795.1 929.4 1,027.5 728.1 585.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 -5 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -5 0 0   EBIT / employee   0 0 0 0 0 -23 0 0   Net earnings / employee   0 0 0 0 0 -24 0 0